{
  "compound": "CBD",
  "condition": "CHRONIC_PAIN",
  "effect_size": "Large (Cohen's d = 1.08)",
  "study_type": "RCT",
  "source": "NORML:CHRONIC_PAIN_RCT_022",
  "participants": "45 adults with sickle cell disease experiencing vaso-occlusive crises",
  "year": 2021,
  "notes": "Cannabidiol for Sickle Cell Disease Pain Crises: A Pilot RCT",
  "confidence": "medium",
  "abstract": "CBD: Mean crisis duration 2.8 days vs Placebo: 4.6 days (39% reduction); pain scores reduced 47% faster with CBD"
}